Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking

by Chuang G, Boyington JC, Nabel GJ, Kwong PD, Georgiev I
Published 2012-09-01

NMR spectroscopy of HIV-1 gp120 outer domain

by Sastry M, Xu L, Bhattacharya S, Nabel GJ, Bewley CA, Kwong PD
Published 2012-09-01

P09-05. Mechanism of HIV-1 resistance to a monoclonal antibody that effectively targets the site of CD4 attachment

by Mascola JR, Kwong PD, Wyatt RT, O'Dell S, Zhou T, Wu X
Published 2009-10-01

P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization

by Kwong PD, Nabel GJ, Burton DR, Hessell AJ, Xu L, Yang Z, Zhou T
Published 2009-10-01

P12-12. Analysis of antibody and B cell responses following inoculation with computationally designed HIV-1 2F5 epitope scaffold proteins

by Hedestam GB, Kwong PD, Schief W, Baker D, Ofek G, Guenaga J, Dosenovic P, Wyatt RT
Published 2009-10-01

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120

by Zhou T, Moquin S, Lynch R, Wu X, Zhu J, Yang Y, Zhang B, Mascola JR, Kwong PD
Published 2012-09-01

Recombinant Env proteins that bind the quaternary-specific, V1/V2-directed PGT antibodies

by Gorman J, McLellan J, Yang Y, Zhou T, Zhu J, Bangaru S, Bayless N, Alff P, Marshall CP, Kwong PD
Published 2012-09-01

Partial germline reversions can increase VRC07 potency and breadth

by Rudicell RS, Georgiev I, Yang Z, O'Dell S, Kwon Y, Zhu J, Wu X, Kwong PD, Mascola JR, Nabel GJ
Published 2012-09-01

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

by Dai K, Boyington JC, Shi W, Schmidt SD, Georgiev I, Lingwood D, Kwong PD, Mascola JR, Yang Z, Nabel GJ
Published 2012-09-01

Structure-guided modification and optimization of antibody VRC07

by Kwon Y, Georgiev I, O'Dell S, Shi W, Chuang G, Yang Y, Zhang B, Zhu J, Nabel GJ, Mascola JR, Kwong PD
Published 2012-09-01

454 pyrosequencing and bioinformatics analysis of the lineage of the broad and potent gp41-directed antibody 10e8

by Ofek G, Zhu J, Yang Y, Zhang B, Mckee K, Louder M, Huang J, Laub L, Connors M, Mascola J, Kwong PD
Published 2012-09-01

V1/V2-directed antibodies elicited in RV144 vaccinees bind to a structurally polymorphic site

by McLellan JS, Gorman J, Bonsignori M, Hwang K, Liao H, Rerks-Ngarm S, Nitayaphan S, Michael NL, Kim JH, Haynes BF, Kwong PD
Published 2012-09-01

Structural definition of a novel CD4-induced epitope that is targeted by a single-headed immunoglobulin to effect broad and potent HIV neutralization

by Acharya P, Luongo TS, Matz J, Schmidt SD, Chuang G, Georgiev I, Kessler P, Yang Y, Chames P, Martin L, Mascola JR, Kwong PD
Published 2012-09-01

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

by Joyce M, Zhang B, Zhou T, Moquin S, Wu X, Louder M, Zhang Z, Georgiev I, Zhu J, Shapiro L, Mascola JR, Nabel GJ, Kwong PD
Published 2012-09-01

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection

by Hahn BH, Yang Y, Wang S, Li H, Salazar M, Salazar-Gonzales J, McLellan J, Decker J, Keele BF, Bar KJ, Kwong PD, Shaw GM
Published 2009-10-01

Design of epitope-specific probes for sera analysis and antibody isolation

by Georgiev I, Acharya P, Schmidt SD, Li Y, Wycuff D, Ofek G, Doria-Rose N, Luongo TS, Yang Y, Zhou T, Donald BR, Mascola JR, Kwong PD
Published 2012-09-01

Deep sequencing with longitudinal sampling of a VRC01-like-antibody response in a chronically infected individual

by Zhang Z, Wu X, Longo N, Zhang B, Zhu J, NISC C, Mullikin JC, Wu L, Nabel GJ, Connors M, Kwong PD, Mascola JR, Shapiro L
Published 2012-09-01

A short segment in the HIV-1 gp120 V1/V2 region is a major determinant of neutralization resistance to PG9-like antibodies

by Doria-Rose NA, Georgiev I, Staupe RP, O'Dell S, Chuang G, Gorman J, McLellan JS, Pancera M, Bonsignori M, Haynes BF, Burton DR, Koff WC, Kwong PD, Mascola JR
Published 2012-09-01

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

by Liao L, Bonsignori M, Hwang K, Moody AM, Park R, Crawford S, Chen H, Jeffries TL, Cooper M, Lu X, De R, Karasavvas N, Rerks-Ngarm S, Nitayaphan S, Kaewkungwal J, Tovanabutra S, Pitisuttithum P, Tartaglia J, Sinangil F, Kim J, Michael NL, Tomaras GD, Yang Z, Dai K, Pancera M, Nabel GJ, Mascola JR, Kwong PD, Pinter A, Zolla-Pazner S, Alam MS, Haynes BF
Published 2012-09-01

Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses

by Chuang, Gwo-Yu, Shen, Chen-Hsiang, Cheung, Crystal Sao-Fong, Gorman, Jason, Creanga, Adrian, Joyce, M. Gordon, Leung, Kwanyee, Rawi, Reda, Wang, Lingshu, Yang, Eun Sung, Yang, Yongping, Zhang, Baoshan, Zhang, Yi, Kanekiyo, Masaru, Zhou, Tongqing, DeKosky, Brandon J., Graham, Barney S., Mascola, John R., Kwong, Peter D.
Published 2021